Document is current
Any future updates will be listed below
-
Authors
Elatrash, Citrine
Wilson, Theresa A.
Wood, Alexis C.
Elsea, Sarah H.
Sisley, Stephanie
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development, United States (R21HD106345)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD106345)
- License Information
-
More Information
Article History
Received: 21 August 2025
Accepted: 21 April 2026
First Online: 29 April 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board at Baylor College of Medicine. All subjects provided either verbal or written consent. Clinical trial number: not applicable.
: Financial interests: Both SHE and SS have received research and consulting funds from Rhythm Pharmaceuticals. SS has received research funds from NIH and Eli Lilly and Company. SHE has research funding from the NIH, PTC Therapeutics, Speragen, Inc, and PRISMS, Inc. PRISMS, Inc. supports the SMS Patient Registry, which is housed at Baylor College of Medicine. All other authors declare no financial conflicts of interest. Non-financial interests: none.
